Session VIII: Esophageal and Gastric Cancers

Thursday, June 29, 2023

10:00 – 13:15 CEST

Location:Auditorium A, Level 0

Chair(s)

Sara De Dosso, MD

Medical Oncology Department, Oncology Institute of Southern Switzerland
Bellinzona, Switzerland
Kohei Shitara, MD

National Cancer Center Hospital East
Kashiwa, Japan

Presentations:

10:00 – 10:20 CEST

Strategy in Oligometastatic Upper GI Cancer
Speaker: Hanneke Van Laarhoven, MD, PhD – Amsterdam UMC
10:20 – 10:30 CEST

O-6: EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients (pts) with resected gastroesophageal adenocarcinoma (GEA) following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)—An open-label randomized controlled phase II study
Abstract Presenter: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
10:30 – 10:40 CEST

O-7: Adjuvant nivolumab vs placebo in resected esophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: First report of comprehensive biomarker analyses from CheckMate 577
Abstract Presenter: Ronan Kelly
10:40 – 11:00 CEST

Are We Ready to Integrate Immunotherapy in Adjuvant and/or Neoadjuvant Settings in Upper GI Cancer? And Discussant (O-6 and O-7)
Speaker: Salah-Eddin Al-Batran, Prof. Dr. – Krankenhaus Nordwest, Frankfurt
11:00 – 11:30 CEST

Keynote Lecture: Molecular Classification of Gastric Cancer
Speaker: Patrick Tan, MD. PhD – Duke-NUS Medical School
11:30 – 11:38 CEST

SO-13: Outcomes and a prognostic classifier in 130 patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade
Abstract Presenter: Giovanni Randon
11:38 – 11:55 CEST

Flash: Locally Advanced MSI-H Upper GI Cancer: What is the Optimal Approach?
Speaker: Filippo Pietrantonio, Dr – Fondazione IRCCS Istituto Nazionale dei Tumori
11:55 – 12:15 CEST

Checkpoint Inhibition in Squamous Cell Cancer of the Esophagus
Speaker: Markus Moehler, MD – Universitätsmedizin Mainz
12:15 – 12:35 CEST

Checkpoint Inhibition in Metastatic Gastric Adenocarcinoma
Speaker: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
12:35 – 12:55 CEST

New Targets and Agents in Upper GI Cancer
Speaker: Kohei Shitara, MD – National Cancer Center Hospital East
12:55 – 13:15 CEST

Q&A and Panel Discussion
Moderator: Sara De Dosso, MD – Medical Oncology Department, Oncology Institute of Southern Switzerland
Moderator: Kohei Shitara, MD – National Cancer Center Hospital East
Panelist: Salah-Eddin Al-Batran, Prof. Dr. – Krankenhaus Nordwest, Frankfurt
Panelist: Markus Moehler, MD – Universitätsmedizin Mainz
Panelist: Filippo Pietrantonio, Dr – Fondazione IRCCS Istituto Nazionale dei Tumori
Panelist: Elizabeth C. Smyth, MD – Oxford Cancer, United Kingdom
Panelist: Patrick Tan, MD. PhD – Duke-NUS Medical School
Panelist: Hanneke Van Laarhoven, MD, PhD – Amsterdam UMC